745P Clinical activity, safety, and PK/PD from the first in human study (NP41300) of RO7247669, a PD1-LAG3 bispecific antibody

Title
745P Clinical activity, safety, and PK/PD from the first in human study (NP41300) of RO7247669, a PD1-LAG3 bispecific antibody
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 33, Issue -, Pages S884-S885
Publisher
Elsevier BV
Online
2022-09-14
DOI
10.1016/j.annonc.2022.07.871

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started